ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0265

Influence of Menopausal Status on Coronary Artery Calcium Burden and Cardiovascular Computed Tomography Abnormalities in Inflammatory Arthritis

Mohammed Mohammed1, Bindee Kuriya2, Lihi Eder1, Elsie Nguyen3, Shadi Ahktari4, Paula Harvey5, Wei Wu6 and Sohan Shahab7, 1University of Toronto, Toronto, ON, Canada, 2University of Toronto - Toronto, Toronto, ON, Canada, 3University of Toronto, Toronto, 4University of Toronto Department of Medicine and Women's College Hospital, Toronto, Canada, 5University of Toronto Department of Medicine and Women's College Hospital, Toronto, ON, Canada, 6University of Toronto, Toronto, Canada, 7Women’s College Research Institute, Women’s College Hospital, Toronto, Canada

Meeting: ACR Convergence 2025

Keywords: Cardiovascular, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0233–0279) Miscellaneous Rheumatic & Inflammatory Diseases Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Patients with inflammatory arthritis (IA) have increased cardiovascular risk. Coronary artery calcium (CAC) scoring by computed tomography (CT) detects early coronary disease and structural abnormalities. While sex and menopause influence CVD risk, their impact on coronary and extra-coronary CT findings in IA is unclear

Methods: We conducted a cross-sectional analysis using data from the U of T CardioRheum Network (2017–2023). Eligible participants were aged >40 years with confirmed IA, and no prior CVD. The primary outcome was total CAC category (0, 1–100, >100); secondary outcomes included plaque distribution and other CT-detected abnormalities. Multivariable logistic regression assessed associations with post-menopausal status, adjusting for confounders.

Results: Among 594 IA patients, 31% were male (mean age 57.3), 14% pre-menopausal female (46.1), and 54% post-menopausal female (61.7). Males were more likely to have AS/PsA (71%) compared to pre-menopausal (38%) and post-menopausal females (30%), while RA was more prevalent in post-menopausal females (70%, p< 0.001). Males had more CVD risk factors and higher Framingham scores (44% vs. 11% post- and 1.5% pre-menopausal females, p< 0.0001). Both female groups had higher joint counts, global, and pain scores (all p< 0.05). DMARD use was highest in post-menopausal females (92%), though biologics were more common in males (58%) and pre-menopausal females (54%) than post-menopausal females (45%) (p=0.01). Corticosteroid use was also higher in post-menopausal females (25%, p=0.01). CAC >100 occurred in 28% of males, 19% of post-, and 1.4% of pre-menopausal females (p< 0.0001). Post-menopausal females had more aortic calcification (44%), aortic enlargement (23%), and pericardial effusion (8%) (all p≤0.001), while males had more left main and right coronary calcification (p≤0.001). In multivariable models, post-menopausal females had lower odds of elevated CAC vs. males (OR 0.31, 95% CI 0.19–0.53). Independent predictors of CAC >100 included older age, higher CRP, smoking, and diabetes. Post-menopausal women had lower odds of CAC in specific coronary territories (left main, right, and circumflex arteries), but there were no adjusted differences in aortic involvement.

Conclusion: Sex and menopausal status significantly influence both coronary and extra-coronary abnormalities detected by CT in IA patients. While men exhibit greater coronary plaque burden, post-menopausal women show a distinct pattern of vascular and structural abnormalities. These findings support a sex-specific approach to cardiovascular risk stratification in IA.

Supporting image 1


Disclosures: M. Mohammed: None; B. Kuriya: AbbVie/Abbott, 1, Pfizer, 1, UCB, 1; L. Eder: AbbVie, 1, 2, 5, 6, BMS, 1, 2, Eli Lilly, 1, 2, 5, 6, Fresenius Kabi, 1, 5, J&J, 1, 2, 5, Janssen, 1, 5, Novartis, 1, 2, 5, 6, Pfizer, 1, 2, 5, UCB, 1, 2, 5; E. Nguyen: None; S. Ahktari: None; P. Harvey: None; W. Wu: None; S. Shahab: None.

To cite this abstract in AMA style:

Mohammed M, Kuriya B, Eder L, Nguyen E, Ahktari S, Harvey P, Wu W, Shahab S. Influence of Menopausal Status on Coronary Artery Calcium Burden and Cardiovascular Computed Tomography Abnormalities in Inflammatory Arthritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/influence-of-menopausal-status-on-coronary-artery-calcium-burden-and-cardiovascular-computed-tomography-abnormalities-in-inflammatory-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/influence-of-menopausal-status-on-coronary-artery-calcium-burden-and-cardiovascular-computed-tomography-abnormalities-in-inflammatory-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology